comparemela.com

Latest Breaking News On - Collplant - Page 1 : comparemela.com

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

/PRNewswire/ CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based.

Israel
Rehovot
Hamerkaz
John-mullaly
Allergan
John-mullaly-at-lifesci-advisors
Plant-biotechnologies
Eastern-daylight
Lifesci-advisors
Collplant-investor
Collplant

Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update

/PRNewswire/ CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based.

Israel
Rehovot
Hamerkaz
John-mullaly
Allergan
Sheba-medical-center
Exchange-commission
Technology-transfer-company-of-tel-aviv-university
Israel-innovation-authority
Company-bioink
Plant-biotechnologies
Chief-executive-officer

vimarsana © 2020. All Rights Reserved.